Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex

Subjects

Abstract

A growing preclinical and clinical body of work on the effects of chronic drug use and drug addiction has extended the scope of inquiry from the putative reward-related subcortical mechanisms to higher-order executive functions as regulated by the prefrontal cortex. Here we review the neuroimaging evidence in humans and non-human primates to demonstrate the involvement of the prefrontal cortex in emotional, cognitive, and behavioral alterations in drug addiction, with particular attention to the impaired response inhibition and salience attribution (iRISA) framework. In support of iRISA, functional and structural neuroimaging studies document a role for the prefrontal cortex in assigning excessive salience to drug over non-drug-related processes with concomitant lapses in self-control, and deficits in reward-related decision-making and insight into illness. Importantly, converging insights from human and non-human primate studies suggest a causal relationship between drug addiction and prefrontal insult, indicating that chronic drug use causes the prefrontal cortex damage that underlies iRISA while changes with abstinence and recovery with treatment suggest plasticity of these same brain regions and functions. We further dissect the overlapping and distinct characteristics of drug classes, potential biomarkers that inform vulnerability and resilience, and advancements in cutting-edge psychological and neuromodulatory treatment strategies, providing a comprehensive landscape of the human and non-human primate drug addiction literature as it relates to the prefrontal cortex.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Disturbances in the drug-addicted brain as described by the iRISA framework.
Fig. 2: The PFC in drug addiction as a function of time.
Fig. 3: The PFC mechanisms of recovery as supported by the iRISA framework.

References

  1. O’Brien CP, Volkow N, Li T-K. What’s in a word? Addiction versus dependence in DSM-V. Am J Psychiatry. 2006;163:764–5.

    PubMed  Google Scholar 

  2. Wise RA. Neurobiology of addiction. Curr Opin Neurobiol. 1996;6:243–51.

    CAS  PubMed  Google Scholar 

  3. Knutson B, Adams CM, Fong GW, Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci. 2001;21:RC159–RC159.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Robinson TE, Gorny G, Mitton E, Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse. 2001;39:257–66.

    CAS  PubMed  Google Scholar 

  5. O’Doherty JP, Dayan P, Schultz J, Deichmann R, Friston K, Dolan RJ. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science. 2004;304:452–4.

    PubMed  Google Scholar 

  6. Balleine BW, O’Doherty JP. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology. 2009;35:48–69.

    PubMed Central  Google Scholar 

  7. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000;10:318–25.

    CAS  PubMed  Google Scholar 

  8. Gläscher J, Hampton AN, O’Doherty JP. Determining a role for ventromedial prefrontal cortex in encoding action-based value signals during reward-related decision making. Cereb Cortex. 2009;19:483–95.

    PubMed  Google Scholar 

  9. Pujara MS, Philippi CL, Motzkin JC, Baskaya MK, Koenigs M. Ventromedial prefrontal cortex damage is associated with decreased ventral striatum volume and response to reward. J Neurosci. 2016;36:5047–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Daw ND, O’Doherty JP, Dayan P, Seymour B, Dolan RJ. Cortical substrates for exploratory decisions in humans. Nature. 2006;441:876–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Brockett AT, Roesch MR. The ever-changing OFC landscape: what neural signals in OFC can tell us about inhibitory control. Behav Neurosci. 2021;135:129–37.

    PubMed  Google Scholar 

  12. Rolls ET, Everitt BJ, Roberts A, Roberts AC, Robbins TW, Weiskrantz L. The orbitofrontal cortex. Philos Trans R Soc Lond Ser B. 1996;351:1433–44.

    CAS  Google Scholar 

  13. O’Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci. 2001;4:95–102.

    PubMed  Google Scholar 

  14. Bechara A, Tranel D, Damasio H. Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain. 2000;123:2189–202.

    PubMed  Google Scholar 

  15. Reber J, Feinstein JS, O’Doherty JP, Liljeholm M, Adolphs R, Tranel D. Selective impairment of goal-directed decision-making following lesions to the human ventromedial prefrontal cortex. Brain. 2017;140:1743–56.

    PubMed  PubMed Central  Google Scholar 

  16. Petrides M, Tomaiuolo F, Yeterian EH, Pandya DN. The prefrontal cortex: comparative architectonic organization in the human and the macaque monkey brains. Cortex. 2012;48:46–57.

    PubMed  Google Scholar 

  17. Aron AR, Behrens TE, Smith S, Frank MJ, Poldrack RA. Triangulating a cognitive control network using diffusion-weighted magnetic resonance imaging (MRI) and functional MRI. J Neurosci. 2007;27:3743–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Dick AS, Garic D, Graziano P, Tremblay P. The frontal aslant tract (FAT) and its role in speech, language and executive function. Cortex. 2019;111:148–63.

    PubMed  Google Scholar 

  19. Sallet J, Mars RB, Noonan MP, Neubert F-X, Jbabdi S, O’Reilly JX, et al. The organization of dorsal frontal cortex in humans and macaques. J Neurosci. 2013;33:12255–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Kane MJ, Engle RW. The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychonomic Bull Rev. 2002;9:637–71.

    Google Scholar 

  21. Goldin PR, McRae K, Ramel W, Gross JJ. The neural bases of emotion regulation: reappraisal and suppression of negative emotion. Biol Psychiatry. 2008;63:577–86.

    PubMed  Google Scholar 

  22. Barbey AK, Koenigs M, Grafman J. Dorsolateral prefrontal contributions to human working memory. Cortex. 2013;49:1195–205.

    PubMed  Google Scholar 

  23. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci. 2001;2:417–24.

    CAS  PubMed  Google Scholar 

  24. Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science. 1998;280:747–9.

    CAS  PubMed  Google Scholar 

  25. Bush G, Vogt BA, Holmes J, Dale AM, Greve D, Jenike MA, et al. Dorsal anterior cingulate cortex: a role in reward-based decision making. PNAS. 2002;99:523–8.

    CAS  PubMed  Google Scholar 

  26. Etkin A, Egner T, Kalisch R. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci. 2011;15:85–93.

    PubMed  Google Scholar 

  27. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159:1642–52.

    PubMed  PubMed Central  Google Scholar 

  28. Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12:652–69.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Zilverstand A, Huang AS, Alia-Klein N, Goldstein RZ. Neuroimaging impaired response inhibition and salience attribution in human drug addiction: a systematic review. Neuron. 2018;98:886–903.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Roberts AC, Clarke HF. Why we need nonhuman primates to study the role of ventromedial prefrontal cortex in the regulation of threat- and reward-elicited responses. PNAS. 2019;116:26297–304.

    CAS  PubMed Central  Google Scholar 

  31. Barbas H, Pandya DN. Architecture and intrinsic connections of the prefrontal cortex in the rhesus monkey. J Comp Neurol. 1989;286:353–75.

    CAS  PubMed  Google Scholar 

  32. Öngür D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000;10:206–19.

    PubMed  Google Scholar 

  33. Yeterian EH, Pandya DN, Tomaiuolo F, Petrides M. The cortical connectivity of the prefrontal cortex in the monkey brain. Cortex. 2012;48:58–81.

    PubMed  Google Scholar 

  34. Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C, Bunn J, et al. Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects. Am J Psychiatry. 2019;176:119–28.

    PubMed  Google Scholar 

  35. Ersche KD, Williams GB, Robbins TW, Bullmore ET. Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience. Curr Opin Neurobiol. 2013;23:615–24.

    CAS  PubMed  Google Scholar 

  36. Tanabe J, Tregellas JR, Dalwani M, Thompson L, Owens E, Crowley T, et al. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol Psychiatry. 2009;65:160–4.

    PubMed  Google Scholar 

  37. Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct. 2010;214:655–67.

    PubMed  PubMed Central  Google Scholar 

  38. MacDonald AW, Cohen JD, Stenger VA, Carter CS. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science. 2000;288:1835–8.

    CAS  PubMed  Google Scholar 

  39. Levy BJ, Wagner AD. Cognitive control and right ventrolateral prefrontal cortex: reflexive reorienting, motor inhibition, and action updating. Ann N Y Acad Sci. 2011;1224:40–62.

    PubMed  PubMed Central  Google Scholar 

  40. Kovach CK, Daw ND, Rudrauf D, Tranel D, O’Doherty JP, Adolphs R. Anterior prefrontal cortex contributes to action selection through tracking of recent reward trends. J Neurosci. 2012;32:8434–42.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Fritz H-C, Wittfeld K, Schmidt CO, Domin M, Grabe HJ, Hegenscheid K, et al. Current smoking and reduced gray matter volume-a voxel-based morphometry study. Neuropsychopharmacology. 2014;39:2594–2600.

    PubMed  PubMed Central  Google Scholar 

  42. Kaag AM, Schulte MHJ, Jansen JM, van Wingen G, Homberg J, van den Brink W, et al. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users. Drug Alcohol Depend. 2018;187:186–94.

    CAS  PubMed  Google Scholar 

  43. Sutherland MT, Riedel MC, Flannery JS, Yanes JA, Fox PT, Stein EA, et al. Chronic cigarette smoking is linked with structural alterations in brain regions showing acute nicotinic drug-induced functional modulations. Behav Brain Funct. 2016;12:16.

    PubMed  PubMed Central  Google Scholar 

  44. Stoeckel LE, Chai XJ, Zhang J, Whitfield-Gabrieli S, Evins AE. Lower gray matter density and functional connectivity in the anterior insula in smokers compared with never smokers. Addict Biol. 2016;21:972–81.

    PubMed  Google Scholar 

  45. Rosenthal A, Beck A, Zois E, Vollstädt-Klein S, Walter H, Kiefer F, et al. Volumetric prefrontal cortex alterations in patients with alcohol dependence and the involvement of self-control. Alcohol Clin Exp Res. 2019;43:2514–24.

    PubMed  PubMed Central  Google Scholar 

  46. Fortier CB, Leritz EC, Salat DH, Venne JR, Maksimovskiy AL, Williams V, et al. Reduced cortical thickness in abstinent alcoholics and association with alcoholic behavior. Alcohol Clin Exp Res. 2011;35:2193–201.

    PubMed  PubMed Central  Google Scholar 

  47. Wiers CE, Gawron CK, Gröpper S, Spengler S, Stuke H, Lindenmeyer J, et al. Decreased gray matter volume in inferior frontal gyrus is related to stop-signal task performance in alcohol-dependent patients. Psychiatry Res. 2015;233:125–30.

    PubMed  Google Scholar 

  48. Wang J, Fan Y, Dong Y, Ma M, Ma Y, Dong Y, et al. Alterations in brain structure and functional connectivity in alcohol dependent patients and possible association with impulsivity. PLoS One. 2016;11:e0161956.

    PubMed  PubMed Central  Google Scholar 

  49. Alia-Klein N, Parvaz MA, Woicik PA, Konova AB, Maloney T, Shumay E, et al. Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. Arch Gen Psychiatry. 2011;68:283–94.

    PubMed  PubMed Central  Google Scholar 

  50. Hall MG, Alhassoon OM, Stern MJ, Wollman SC, Kimmel CL, Perez-Figueroa A, et al. Gray matter abnormalities in cocaine versus methamphetamine-dependent patients: a neuroimaging meta-analysis. Am J Drug Alcohol Abus. 2015;41:290–9.

    Google Scholar 

  51. Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA, et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry. 2002;51:134–42.

    CAS  PubMed  Google Scholar 

  52. Yip SW, Worhunsky PD, Xu J, Morie KP, Constable RT, Malison RT, et al. Gray-matter relationships to diagnostic and transdiagnostic features of drug and behavioral addictions. Addict Biol. 2018;23:394–402.

    CAS  PubMed  Google Scholar 

  53. Hirsiger S, Hänggi J, Germann J, Vonmoos M, Preller KH, Engeli EJE, et al. Longitudinal changes in cocaine intake and cognition are linked to cortical thickness adaptations in cocaine users. Neuroimage Clin. 2019;21:101652.

    PubMed  PubMed Central  Google Scholar 

  54. Smith DG, Jones PS, Williams GB, Bullmore ET, Robbins TW, Ersche KD. Overlapping decline in orbitofrontal gray matter volume related to cocaine use and body mass index. Addict Biol. 2015;20:194–6.

    PubMed  Google Scholar 

  55. Matuskey D, Bhagwagar Z, Planeta B, Pittman B, Gallezot J-D, Chen J, et al. Reductions in brain 5-HT1B receptor availability in primarily cocaine-dependent humans. Biol Psychiatry. 2014;76:816–22.

    CAS  PubMed  Google Scholar 

  56. Konova AB, Moeller SJ, Tomasi D, Parvaz MA, Alia-Klein N, Volkow ND, et al. Structural and behavioral correlates of abnormal encoding of money value in the sensorimotor striatum in cocaine addiction. Eur J Neurosci. 2012;36:2979–88.

    PubMed  PubMed Central  Google Scholar 

  57. Moreno-López L, Catena A, Fernández-Serrano MJ, Delgado-Rico E, Stamatakis EA, Pérez-García M, et al. Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals. Drug Alcohol Depend. 2012;125:208–14.

    PubMed  Google Scholar 

  58. Wollman SC, Alhassoon OM, Hall MG, Stern MJ, Connors EJ, Kimmel CL, et al. Gray matter abnormalities in opioid-dependent patients: a neuroimaging meta-analysis. Am J Drug Alcohol Abus. 2017;43:505–17.

    Google Scholar 

  59. Liu H, Hao Y, Kaneko Y, Ouyang X, Zhang Y, Xu L, et al. Frontal and cingulate gray matter volume reduction in heroin dependence: optimized voxel-based morphometry. Psychiatry Clin Neurosci. 2009;63:563–8.

    PubMed  Google Scholar 

  60. Yuan Y, Zhu Z, Shi J, Zou Z, Yuan F, Liu Y, et al. Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals. Brain Cogn. 2009;71:223–8.

    PubMed  Google Scholar 

  61. Shi H, Liang Z, Chen J, Li W, Zhu J, Li Y, et al. Gray matter alteration in heroin-dependent men: an atlas-based magnetic resonance imaging study. Psychiatry Res Neuroimaging. 2020;304:111150.

    PubMed  PubMed Central  Google Scholar 

  62. Wang X, Li B, Zhou X, Liao Y, Tang J, Liu T, et al. Changes in brain gray matter in abstinent heroin addicts. Drug Alcohol Depend. 2012;126:304–8.

    CAS  PubMed  Google Scholar 

  63. Lin H-C, Wang P-W, Wu H-C, Ko C-H, Yang Y-H, Yen C-F. Altered gray matter volume and disrupted functional connectivity of dorsolateral prefrontal cortex in men with heroin dependence. Psychiatry Clin Neurosci. 2018;72:435–44.

    PubMed  Google Scholar 

  64. Li M, Tian J, Zhang R, Qiu Y, Wen X, Ma X, et al. Abnormal cortical thickness in heroin-dependent individuals. Neuroimage. 2014;88:295–307.

    CAS  PubMed  Google Scholar 

  65. Hanlon CA, Owens MM, Joseph JE, Zhu X, George MS, Brady KT, et al. Lower subcortical gray matter volume in both younger smokers and established smokers relative to non-smokers. Addict Biol. 2016;21:185–95.

    PubMed  Google Scholar 

  66. Fein G, Di Sclafani V, Cardenas VA, Goldmann H, Tolou-Shams M, Meyerhoff DJ. Cortical gray matter loss in treatment-naïve alcohol dependent individuals. Alcohol Clin Exp Res. 2002;26:558–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Barrós-Loscertales A, Garavan H, Bustamante JC, Ventura-Campos N, Llopis JJ, Belloch V, et al. Reduced striatal volume in cocaine-dependent patients. Neuroimage. 2011;56:1021–6.

    PubMed  Google Scholar 

  68. Connolly CG, Bell RP, Foxe JJ, Garavan H. Dissociated grey matter changes with prolonged addiction and extended abstinence in cocaine users. PLoS One. 2013;8:e59645.

  69. Durazzo TC, Mon A, Gazdzinski S, Yeh P-H, Meyerhoff DJ. Serial longitudinal magnetic resonance imaging data indicate non-linear regional gray matter volume recovery in abstinent alcohol-dependent individuals. Addict Biol. 2015;20:956–67.

    PubMed  Google Scholar 

  70. Parvaz MA, Moeller SJ, d’Oleire Uquillas F, Pflumm A, Maloney T, Alia-Klein N, et al. Prefrontal gray matter volume recovery in treatment-seeking cocaine-addicted individuals: a longitudinal study. Addict Biol. 2017;22:1391–401.

    CAS  PubMed  Google Scholar 

  71. Durazzo TC, Mon A, Gazdzinski S, Meyerhoff DJ. Regional brain volume changes in alcohol-dependent individuals during early abstinence: associations with relapse following treatment. Addict Biol. 2017;22:1416–25.

    PubMed  Google Scholar 

  72. Rando K, Hong K-I, Bhagwagar Z, Li C-SR, Bergquist K, Guarnaccia J, et al. Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: a prospective study. Am J Psychiatry. 2011;168:183–92.

    PubMed  Google Scholar 

  73. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. Abnormal brain structure implicated in stimulant drug addiction. Science. 2012;335:601–4.

    CAS  PubMed  Google Scholar 

  74. Lotfipour S, Ferguson E, Leonard G, Perron M, Pike B, Richer L, et al. Orbitofrontal cortex and drug use during adolescence: role of prenatal exposure to maternal smoking and BDNF genotype. Arch Gen Psychiatry. 2009;66:1244.

    PubMed  Google Scholar 

  75. Kühn S, Witt C, Banaschewski T, Barbot A, Barker GJ, Büchel C, et al. From mother to child: orbitofrontal cortex gyrification and changes of drinking behaviour during adolescence. Addiction Biol. 2016;21:700–8.

    Google Scholar 

  76. Ersche KD, Jones PS, Williams GB, Smith DG, Bullmore ET, Robbins TW. Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence. Biol Psychiatry. 2013;74:137–44.

    PubMed  PubMed Central  Google Scholar 

  77. Song X, García-Saldivar P, Kindred N, Wang Y, Merchant H, Meguerditchian A, et al. Strengths and challenges of longitudinal non-human primate neuroimaging. NeuroImage. 2021;236:118009.

    PubMed  Google Scholar 

  78. Kroenke CD, Rohlfing T, Park B, Sullivan EV, Pfefferbaum A, Grant KA. Monkeys that voluntarily and chronically drink alcohol damage their brains: a longitudinal MRI study. Neuropsychopharmacology. 2014;39:823–30.

    CAS  PubMed  Google Scholar 

  79. Jedema HP, Song X, Aizenstein HJ, Bonner AR, Stein EA, Yang Y, et al. Long-term cocaine self-administration produces structural brain changes that correlate with altered cognition. Biol Psychiatry. 2021;89:376–85.

    PubMed  Google Scholar 

  80. Carvalho M, Carmo H, Costa VM, Capela JP, Pontes H, Remião F, et al. Toxicity of amphetamines: an update. Arch Toxicol. 2012;86:1167–231.

    CAS  PubMed  Google Scholar 

  81. Kousik SM, Napier TC, Carvey PM. The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front Pharmacol. 2012;3:121.

  82. De Erausquin GA, Alba-Ferrara L. What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia. Front Integr Neurosci. 2013;7:9.

  83. Soares J, Marques P, Alves V, Sousa N. A hitchhiker’s guide to diffusion tensor imaging. Front Neurosci. 2013;7:31.

  84. Song S-K, Yoshino J, Le TQ, Lin S-J, Sun S-W, Cross AH, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage. 2005;26:132–40.

    PubMed  Google Scholar 

  85. Loy DN, Kim JH, Xie M, Schmidt RE, Trinkaus K, Song S-K. Diffusion tensor imaging predicts hyperacute spinal cord injury severity. J Neurotrauma. 2007;24:979–90.

    PubMed  Google Scholar 

  86. Winklewski PJ, Sabisz A, Naumczyk P, Jodzio K, Szurowska E, Szarmach A. Understanding the physiopathology behind axial and radial diffusivity changes—what do we know? Front Neurol. 2018;9:92.

  87. Della Nave R, Ginestroni A, Diciotti S, Salvatore E, Soricelli A, Mascalchi M. Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich’s ataxia. Neuroradiology. 2011;53:367–72.

    PubMed  Google Scholar 

  88. Hampton WH, Hanik IM, Olson IR. Substance abuse and white matter: findings, limitations, and future of diffusion tensor imaging research. Drug Alcohol Depend. 2019;197:288–98.

    PubMed  PubMed Central  Google Scholar 

  89. Lin F, Wu G, Zhu L, Lei H. Heavy smokers show abnormal microstructural integrity in the anterior corpus callosum: a diffusion tensor imaging study with tract-based spatial statistics. Drug Alcohol Depend. 2013;129:82–87.

    CAS  PubMed  Google Scholar 

  90. Baeza-Loya S, Velasquez KM, Molfese DL, Viswanath H, Curtis KN, Thompson-Lake DGY, et al. Anterior cingulum white matter is altered in tobacco smokers. Am J Addict. 2016;25:210–4.

    PubMed  Google Scholar 

  91. Savjani RR, Velasquez KM, Thompson-Lake DGY, Baldwin PR, Eagleman DM, De La Garza R, et al. Characterizing white matter changes in cigarette smokers via diffusion tensor imaging. Drug Alcohol Depend. 2014;145:134–42.

    PubMed  Google Scholar 

  92. Fortier CB, Leritz EC, Salat DH, Lindemer E, Maksimovskiy AL, Shepel J, et al. Widespread effects of alcohol on white matter microstructure. Alcohol Clin Exp Res. 2014;38:2925–33.

    PubMed  PubMed Central  Google Scholar 

  93. Jansen JM, van Holst RJ, van den Brink W, Veltman DJ, Caan MWA, Goudriaan AE. Brain function during cognitive flexibility and white matter integrity in alcohol-dependent patients, problematic drinkers and healthy controls. Addict Biol. 2015;20:979–89.

    PubMed  Google Scholar 

  94. Ashtari M, Cervellione K, Cottone J, Ardekani BA, Kumra S. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J Psychiatr Res. 2009;43:189–204.

    PubMed  PubMed Central  Google Scholar 

  95. Gruber SA, Silveri MM, Dahlgren MK, Yurgelun-Todd D. Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Exp Clin Psychopharmacol. 2011;19:231–42.

    PubMed  PubMed Central  Google Scholar 

  96. Filbey FM, Aslan S, Calhoun VD, Spence JS, Damaraju E, Caprihan A, et al. Long-term effects of marijuana use on the brain. Proc Natl Acad Sci USA. 2014;111:16913–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  97. Suchting R, Beard CL, Schmitz JM, Soder HE, Yoon JH, Hasan KM, et al. A meta-analysis of tract-based spatial statistics studies examining white matter integrity in cocaine use disorder. Addiction Biol. 2021;26:e12902.

    CAS  Google Scholar 

  98. He Q, Li D, Turel O, Bechara A, Hser Y-I. White matter integrity alternations associated with cocaine dependence and long-term abstinence: preliminary findings. Behavioural Brain Res. 2020;379:112388.

    Google Scholar 

  99. Romero MJ, Asensio S, Palau C, Sanchez A, Romero FJ. Cocaine addiction: diffusion tensor imaging study of the inferior frontal and anterior cingulate white matter. Psychiatry Res. 2010;181:57–63.

    CAS  PubMed  Google Scholar 

  100. van Son D, Wiers RW, Catena A, Perez-Garcia M, Verdejo-García A. White matter disruptions in male cocaine polysubstance users: associations with severity of drug use and duration of abstinence. Drug Alcohol Depend. 2016;168:247–54.

    PubMed  Google Scholar 

  101. Lederer K, Fouche J-P, Wilson D, Stein DJ, Uhlmann A. Frontal white matter changes and aggression in methamphetamine dependence. Metab Brain Dis. 2016;31:53–62.

    CAS  PubMed  Google Scholar 

  102. Bora E, Yücel M, Fornito A, Pantelis C, Harrison BJ, Cocchi L, et al. White matter microstructure in opiate addiction. Addict Biol. 2012;17:141–8.

    CAS  PubMed  Google Scholar 

  103. Wollman SC, Alhassoon OM, Stern MJ, Hall MG, Rompogren J, Kimmel CL, et al. White matter abnormalities in long-term heroin users: a preliminary neuroimaging meta-analysis. Am J Drug Alcohol Abus. 2015;41:133–8.

    Google Scholar 

  104. Wang Y, Li W, Li Q, Yang W, Zhu J, Wang W. White matter impairment in heroin addicts undergoing methadone maintenance treatment and prolonged abstinence: a preliminary DTI study. Neurosci Lett. 2011;494:49–53.

    CAS  PubMed  Google Scholar 

  105. Li W, Zhu J, Li Q, Ye J, Chen J, Liu J, et al. Brain white matter integrity in heroin addicts during methadone maintenance treatment is related to relapse propensity. Brain Behav. 2016;6:e00436.

    PubMed  PubMed Central  Google Scholar 

  106. Liu H, Li L, Hao Y, Cao D, Xu L, Rohrbaugh R, et al. Disrupted white matter integrity in heroin dependence: a controlled study utilizing diffusion tensor imaging. Am J Drug Alcohol Abus. 2008;34:562–75.

    Google Scholar 

  107. Wang X, Yu R, Zhou X, Liao Y, Tang J, Liu T, et al. Reversible brain white matter microstructure changes in heroin addicts: a longitudinal study. Addict Biol. 2013;18:727–8.

    PubMed  Google Scholar 

  108. Li W, Li Q, Zhu J, Qin Y, Zheng Y, Chang H, et al. White matter impairment in chronic heroin dependence: a quantitative DTI study. Brain Res. 2013;1531:58–64.

    CAS  PubMed  Google Scholar 

  109. Smith HR, Beveridge TJR, Nader MA, Porrino LJ. Regionally-specific alterations in myelin proteins in nonhuman primate white matter following prolonged cocaine self-administration. Drug Alcohol Depend. 2014;137:143–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  110. Smith HR, Beveridge TJR, Nader SH, Nader MA, Porrino LJ. Regional elevations in microglial activation and cerebral glucose utilization in frontal white matter tracts of rhesus monkeys following prolonged cocaine self-administration. Brain Struct Funct. 2019;224:1417–28.

    CAS  PubMed  PubMed Central  Google Scholar 

  111. Aron AR, Poldrack RA. Cortical and subcortical contributions to stop signal response inhibition: role of the subthalamic nucleus. J Neurosci. 2006;26:2424–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  112. Cole MW, Schneider W. The cognitive control network: Integrated cortical regions with dissociable functions. NeuroImage. 2007;37:343–60.

    PubMed  Google Scholar 

  113. Garavan H, Ross TJ, Murphy K, Roche RAP, Stein EA. Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction. Neuroimage. 2002;17:1820–9.

    CAS  PubMed  Google Scholar 

  114. Gomez P, Ratcliff R, Perea M. A model of the Go/No-Go task. J Exp Psychol Gen. 2007;136:389–413.

    PubMed  PubMed Central  Google Scholar 

  115. Verbruggen F, Logan GD. Response inhibition in the stop-signal paradigm. Trends Cogn Sci. 2008;12:418–24.

    PubMed  PubMed Central  Google Scholar 

  116. Jensen AR, Rohwer WD. The stroop color-word test: a review. Acta Psychol. 1966;25:36–93.

    CAS  Google Scholar 

  117. Luijten M, Veltman DJ, Hester R, Smits M, Nijs IMT, Pepplinkhuizen L, et al. The role of dopamine in inhibitory control in smokers and non-smokers: a pharmacological fMRI study. Eur Neuropsychopharmacol. 2013;23:1247–56.

    CAS  PubMed  Google Scholar 

  118. Eldreth DA, Matochik JA, Cadet JL, Bolla KI. Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage. 2004;23:914–20.

    PubMed  Google Scholar 

  119. Kober H, DeVito EE, DeLeone CM, Carroll KM, Potenza MN. Cannabis abstinence during treatment and one-year follow-up: relationship to neural activity in men. Neuropsychopharmacology. 2014;39:2288–98.

    CAS  PubMed  PubMed Central  Google Scholar 

  120. Li C-SR, Luo X, Yan P, Bergquist K, Sinha R. Altered impulse control in alcohol dependence: neural measures of stop signal performance. Alcohol Clin Exp Res. 2009;33:740–50.

    PubMed  PubMed Central  Google Scholar 

  121. Kaufman JN, Ross TJ, Stein EA, Garavan H. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci. 2003;23:7839–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  122. Li CR, Huang C, Yan P, Bhagwagar Z, Milivojevic V, Sinha R. Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men. Neuropsychopharmacology. 2008;33:1798–806.

    CAS  PubMed  Google Scholar 

  123. Moeller SJ, Froböse MI, Konova AB, Misyrlis M, Parvaz MA, Goldstein RZ, et al. Common and distinct neural correlates of inhibitory dysregulation: Stroop fMRI study of cocaine addiction and intermittent explosive disorder. J Psychiatr Res. 2014;0:55–62.

    PubMed Central  Google Scholar 

  124. Barrós-Loscertales A, Bustamante J-C, Ventura-Campos N, Llopis J-J, Parcet M-A, Ávila C. Lower activation in the right frontoparietal network during a counting Stroop task in a cocaine-dependent group. Psychiatry Res. 2011;194:111–8.

    PubMed  Google Scholar 

  125. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci. 2004;24:11017–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  126. Fu L, Bi G, Zou Z, Wang Y, Ye E, Ma L, et al. Impaired response inhibition function in abstinent heroin dependents: an fMRI study. Neurosci Lett. 2008;438:322–6.

    CAS  PubMed  Google Scholar 

  127. Lee TMC, Zhou W, Luo X, Yuen KSL, Ruan X, Weng X. Neural activity associated with cognitive regulation in heroin users: a fMRI study. Neurosci Lett. 2005;382:211–6.

    CAS  PubMed  Google Scholar 

  128. Luijten M, O’Connor DA, Rossiter S, Franken IHA, Hester R. Effects of reward and punishment on brain activations associated with inhibitory control in cigarette smokers. Addiction. 2013;108:1969–78.

    PubMed  Google Scholar 

  129. Hu S, Ide JS, Zhang S, Sinha R, Li CR. Conflict anticipation in alcohol dependence — a model-based fMRI study of stop signal task. NeuroImage Clin. 2015;8:39–50.

    PubMed  PubMed Central  Google Scholar 

  130. Luijten M, Machielsen MWJ, Veltman DJ, Hester R, de Haan L, Franken IHA. Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people with substance dependence and behavioural addictions. J Psychiatry Neurosci. 2014;39:149–69.

    PubMed  PubMed Central  Google Scholar 

  131. Jentsch JD, Olausson P, De La Garza R, Taylor JR. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology. 2002;26:183–90.

    CAS  PubMed  Google Scholar 

  132. Butter CM. Perseveration in extinction and in discrimination reversal tasks following selective frontal ablations in Macaca mulatta. Physiol Behav. 1969;4:163–71.

    Google Scholar 

  133. Porter JN, Olsen AS, Gurnsey K, Dugan BP, Jedema HP, Bradberry CW. Chronic cocaine self-administration in rhesus monkeys: impact on associative learning, cognitive control, and working memory. J Neurosci. 2011;31:4926–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  134. Gould RW, Gage HD, Nader MA. Effects of chronic cocaine self-administration on cognition and cerebral glucose utilization in rhesus monkeys. Biol Psychiatry. 2012;72:856–63.

    CAS  PubMed  PubMed Central  Google Scholar 

  135. Field M, Cox WM. Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug Alcohol Depend. 2008;97:1–20.

    PubMed  Google Scholar 

  136. Onken LS, Blaine JD, Boren JJ. Behavioral treatments for drug abuse and dependence. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Drug Abuse; 1993.

  137. Waters AJ, Marhe R, Franken IHA. Attentional bias to drug cues is elevated before and during temptations to use heroin and cocaine. Psychopharmacology. 2012;219:909–21.

    CAS  PubMed  Google Scholar 

  138. Smith DG, Ersche KD. Using a drug-word Stroop task to differentiate recreational from dependent drug use. CNS Spectr. 2014;19:247–55.

    PubMed  Google Scholar 

  139. Goldstein RZ, Tomasi D, Alia-Klein N, Carrillo JH, Maloney T, Woicik PA, et al. Dopaminergic response to drug words in cocaine addiction. J Neurosci. 2009;29:6001–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  140. Goldstein RZ, Alia-Klein N, Tomasi D, Carrillo JH, Maloney T, Woicik PA, et al. Anterior cingulate cortex hypoactivations to an emotionally salient task in cocaine addiction. Proc Natl Acad Sci USA. 2009;106:9453–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  141. Denomme WJ, Shane MS. History of withdrawal modulates drug- and food-cue reactivity in cocaine dependent participants. Drug Alcohol Depend. 2020;208:107815.

    CAS  PubMed  Google Scholar 

  142. Luijten M, Veltman DJ, van den Brink W, Hester R, Field M, Smits M, et al. Neurobiological substrate of smoking-related attentional bias. Neuroimage. 2011;54:2374–81.

    PubMed  Google Scholar 

  143. Gilman JM, Radoman M, Schuster RM, Pachas G, Azzouz N, Fava M, et al. Anterior insula activation during inhibition to smoking cues is associated with ability to maintain tobacco abstinence. Addict Behav Rep. 2018;7:40–46.

    PubMed  PubMed Central  Google Scholar 

  144. Vollstädt‐Klein S, Loeber S, Richter A, Kirsch M, Bach P, Goltz Cvonder, et al. Validating incentive salience with functional magnetic resonance imaging: association between mesolimbic cue reactivity and attentional bias in alcohol-dependent patients. Addiction Biol. 2012;17:807–16.

    Google Scholar 

  145. Ames SL, Wong SW, Bechara A, Cappelli C, Dust M, Grenard JL, et al. Neural correlates of a Go/NoGo task with alcohol stimuli in light and heavy young drinkers. Behav Brain Res. 2014;0:382–9.

    PubMed Central  Google Scholar 

  146. Czapla M, Baeuchl C, Simon JJ, Richter B, Kluge M, Friederich H-C, et al. Do alcohol-dependent patients show different neural activation during response inhibition than healthy controls in an alcohol-related fMRI go/no-go-task? Psychopharmacology. 2017;234:1001–15.

    CAS  PubMed  Google Scholar 

  147. Hester R, Garavan H. Neural mechanisms underlying drug-related cue distraction in active cocaine users. Pharm Biochem Behav. 2009;93:270–7.

    CAS  Google Scholar 

  148. Marhe R, Luijten M, van de Wetering BJM, Smits M, Franken IHA. Individual differences in anterior cingulate activation associated with attentional bias predict cocaine use after treatment. Neuropsychopharmacology. 2013;38:1085–93.

    PubMed  PubMed Central  Google Scholar 

  149. Allenby C, Falcone M, Wileyto EP, Cao W, Bernardo L, Ashare RL, et al. Neural cue reactivity during acute abstinence predicts short-term smoking relapse. Addict Biol. 2019. https://doi.org/10.1111/adb.12733.

    Article  PubMed  PubMed Central  Google Scholar 

  150. Janes AC, Pizzagalli DA, Richardt S, deB Frederick B, Chuzi S, Pachas G, et al. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry. 2010;67:722–9.

    PubMed  PubMed Central  Google Scholar 

  151. George O, Koob GF. Control of craving by the prefrontal cortex. Proc Natl Acad Sci USA. 2013;110:4165–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  152. Hayashi T, Ko JH, Strafella AP, Dagher A. Dorsolateral prefrontal and orbitofrontal cortex interactions during self-control of cigarette craving. Proc Natl Acad Sci USA. 2013;110:4422–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  153. Baeg EH, Jackson ME, Jedema HP, Bradberry CW. Orbitofrontal and anterior cingulate cortex neurons selectively process cocaine-associated environmental cues in the rhesus monkey. J Neurosci. 2009;29:11619–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  154. Shidara M, Richmond BJ. Anterior cingulate: single neuronal signals related to degree of reward expectancy. Science. 2002;296:1709–11.

    PubMed  Google Scholar 

  155. Arcurio LR, Finn PR, James TW. Neural mechanisms of high-risk decisions-to-drink in alcohol-dependent women. Addiction Biol. 2015;20:390–406.

    CAS  Google Scholar 

  156. Gowin JL, May AC, Wittmann M, Tapert SF, Paulus MP. Doubling down: increased risk-taking behavior following a loss by individuals with cocaine use disorder is associated with striatal and anterior cingulate dysfunction. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2:94–103.

    PubMed  PubMed Central  Google Scholar 

  157. Yamamoto DJ, Reynolds J, Krmpotich T, Banich MT, Thompson L, Tanabe J. Temporal profile of fronto-striatal-limbic activity during implicit decisions in drug dependence. Drug Alcohol Depend. 2014;136:108–14.

    PubMed  PubMed Central  Google Scholar 

  158. Wesley MJ, Hanlon CA, Porrino LJ. Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. Psychiatry Res. 2011;191:51–59.

    PubMed  Google Scholar 

  159. Tanabe J, Reynolds J, Krmpotich T, Claus E, Thompson LL, Du YP, et al. Reduced neural tracking of prediction error in substance-dependent individuals. Am J Psychiatry. 2013;170:1356–63.

    PubMed  PubMed Central  Google Scholar 

  160. Beylergil SB, Beck A, Deserno L, Lorenz RC, Rapp MA, Schlagenhauf F, et al. Dorsolateral prefrontal cortex contributes to the impaired behavioral adaptation in alcohol dependence. Neuroimage Clin. 2017;15:80–94.

    PubMed  PubMed Central  Google Scholar 

  161. Stewart JL, May AC, Poppa T, Davenport PW, Tapert SF, Paulus MP. You are the danger: attenuated insula response in methamphetamine users during aversive interoceptive decision-making. Drug Alcohol Depend. 2014;0:110–9.

    CAS  PubMed Central  Google Scholar 

  162. Gradin VB, Baldacchino A, Balfour D, Matthews K, Steele JD. Abnormal brain activity during a reward and loss task in opiate-dependent patients receiving methadone maintenance therapy. Neuropsychopharmacology. 2014;39:885–94.

    CAS  PubMed  Google Scholar 

  163. Balodis IM, Potenza MN. Anticipatory reward processing in addicted populations: a focus on the monetary incentive delay task. Biol Psychiatry. 2015;77:434–44.

    PubMed  Google Scholar 

  164. Nestor LJ, Suckling J, Ersche KD, Murphy A, McGonigle J, Orban C, et al. Disturbances across whole brain networks during reward anticipation in an abstinent addiction population. NeuroImage Clin. 2020;27:102297.

    PubMed  PubMed Central  Google Scholar 

  165. Claus ED, Shane MS. dACC response to presentation of negative feedback predicts stimulant dependence diagnosis and stimulant use severity. Neuroimage Clin. 2018;20:16–23.

    PubMed  PubMed Central  Google Scholar 

  166. Li CR, Milivojevic V, Kemp K, Hong K, Sinha R. Performance monitoring and stop signal inhibition in abstinent patients with cocaine dependence. Drug Alcohol Depend. 2006;85:205–12.

    CAS  PubMed  Google Scholar 

  167. Ebitz RB, Sleezer BJ, Jedema HP, Bradberry CW, Hayden BY. Tonic exploration governs both flexibility and lapses. PLoS Comput Biol. 2019;15:e1007475.

    PubMed  PubMed Central  Google Scholar 

  168. Moeller SJ, Platt JM, Wu M, Goodwin RD. Perception of treatment need among adults with substance use disorders: longitudinal data from a representative sample of adults in the United States. Drug Alcohol Depend. 2020;209:107895.

    PubMed  PubMed Central  Google Scholar 

  169. Moeller SJ, Goodwin RD, Sullivan RM, Verdejo-Garcia A. Chapter 26 - Drug use and self-awareness of treatment need: an exemplar of how population-based survey studies can address questions relevant to the neuroscience of insight. In: Verdejo-Garcia A, editor. Cognition and Addiction, London: Academic Press; 2020. p. 351–64.

  170. McLellan AT, Meyers K. Contemporary addiction treatment: A review of systems problems for adults and adolescents. Biol Psychiatry. 2004;56:764–70.

    PubMed  Google Scholar 

  171. Gopalkrishnan N, Babacan H. Cultural diversity and mental health. Australas Psychiatry. 2015;23:6–8.

    PubMed  Google Scholar 

  172. Hester R, Nestor L, Garavan H. Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology. 2009;34:2450–8.

    PubMed  Google Scholar 

  173. Hester R, Simões-Franklin C, Garavan H. Post-error behavior in active cocaine users: poor awareness of errors in the presence of intact performance adjustments. Neuropsychopharmacology. 2007;32:1974–84.

    CAS  PubMed  Google Scholar 

  174. Moeller SJ, Maloney T, Parvaz MA, Dunning JP, Alia-Klein N, Woicik PA, et al. Enhanced choice for viewing cocaine pictures in cocaine addiction. Biol Psychiatry. 2009;66:169–76.

    PubMed  PubMed Central  Google Scholar 

  175. Moeller SJ, Konova AB, Parvaz MA, Tomasi D, Lane RD, Fort C, et al. Functional, structural, and emotional correlates of impaired insight in cocaine addiction. JAMA Psychiatry. 2014;71:61–70.

    PubMed  PubMed Central  Google Scholar 

  176. Moeller SJ, Maloney T, Parvaz MA, Alia-Klein N, Woicik PA, Telang F, et al. Impaired insight in cocaine addiction: laboratory evidence and effects on cocaine-seeking behaviour. Brain. 2010;133:1484–93.

    PubMed  PubMed Central  Google Scholar 

  177. Fleming SM, Weil RS, Nagy Z, Dolan RJ, Rees G. Relating introspective accuracy to individual differences in brain structure. Science. 2010;329:1541–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  178. Moeller SJ, Fleming SM, Gan G, Zilverstand A, Malaker P, d’Oleire Uquillas F, et al. Metacognitive impairment in active cocaine use disorder is associated with individual differences in brain structure. Eur Neuropsychopharmacol. 2016;26:653–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  179. Lucantonio F, Takahashi Y, Hoffman AF, Chang CY, Chaudhary S, Shaham Y, et al. Orbitofrontal activation restores insight lost after cocaine use. Nat Neurosci. 2014;17:1092–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  180. Steptoe A, Wardle J, Smith H, Kopp M, Skrabski A, Vinck J, et al. Tobacco smoking in young adults from 21 European countries: association with attitudes and risk awareness. Addiction. 1995;90:571–82.

    CAS  PubMed  Google Scholar 

  181. Kim JS, Park BK, Kim GJ, Kim SS, Jung JG, Oh MK, et al. The role of alcoholics’ insight in abstinence from alcohol in male Korean alcohol dependents. J Korean Med Sci. 2007;22:132–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  182. Badiani A, Belin D, Epstein D, Calu D, Shaham Y. Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci. 2011;12:685–700.

    CAS  PubMed  PubMed Central  Google Scholar 

  183. Schmahmann JD, Pandya D. Fiber pathways of the brain. Oxford University Press, New York, USA; 2009.

  184. Wardlaw JM, Valdés Hernández MC, Muñoz-Maniega S. What are white matter hyperintensities made of? J Am Heart Assoc. 2015;4:e001140.

  185. Lyoo IK, Streeter CC, Ahn KH, Lee HK, Pollack MH, Silveri MM, et al. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 2004;131:135–45.

    PubMed  Google Scholar 

  186. Kaufman MJ. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA. 1998;279:376.

    CAS  PubMed  Google Scholar 

  187. Bartzokis G, Goldstein IB, Hance DB, Beckson M, Shapiro D, Lu PH, et al. The incidence of T2-weighted MR imaging signal abnormalities in the brain of cocaine-dependent patients is age-related and region-specific. AJNR Am J Neuroradiol. 1999;20:1628–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  188. Bachi K, Mani V, Kaufman AE, Alie N, Goldstein RZ, Fayad ZA, et al. Imaging plaque inflammation in asymptomatic cocaine addicted individuals with simultaneous positron emission tomography/magnetic resonance imaging. World J Radiol. 2019;11:62–73.

    PubMed  PubMed Central  Google Scholar 

  189. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology. 1999;20:322–39.

    CAS  PubMed  Google Scholar 

  190. Ersche KD, Fletcher PC, Lewis SJG, Clark L, Stocks-Gee G, London M, et al. Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals. Psychopharmacology. 2005;180:612–23.

    CAS  PubMed  PubMed Central  Google Scholar 

  191. De Pirro S, Galati G, Pizzamiglio L, Badiani A. The affective and neural correlates of heroin versus cocaine use in addiction are influenced by environmental setting but in opposite directions. J Neurosci. 2018;38:5182–95.

    PubMed  PubMed Central  Google Scholar 

  192. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. AJP. 2008;165:179–87.

    Google Scholar 

  193. Carroll KM. A cognitive-behavioral approach: treating cocaine addiction. U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Maryland, USA; 1998.

  194. Zilverstand A, Parvaz MA, Moeller SJ, Goldstein RZ. Chapter 13—Cognitive interventions for addiction medicine: understanding the underlying neurobiological mechanisms. In: Ekhtiari H, Paulus MP, editors. Progress in Brain Research, vol. 224, Amsterdam: Elsevier; 2016. p. 285–304.

  195. Bari A, Robbins TW. Inhibition and impulsivity: Behavioral and neural basis of response control. Prog Neurobiol. 2013;108:44–79.

    PubMed  Google Scholar 

  196. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005;8:1481–9.

    CAS  PubMed  Google Scholar 

  197. Kober H, Mende-Siedlecki P, Kross EF, Weber J, Mischel W, Hart CL, et al. Prefrontal–striatal pathway underlies cognitive regulation of craving. PNAS. 2010;107:14811–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  198. Zhao L-Y, Tian J, Wang W, Qin W, Shi J, Li Q, et al. The role of dorsal anterior cingulate cortex in the regulation of craving by reappraisal in smokers. PLOS One. 2012;7:e43598.

    CAS  PubMed  PubMed Central  Google Scholar 

  199. Suzuki S, Mell MM, O’Malley SS, Krystal JH, Anticevic A, Kober H. Regulation of craving and negative emotion in alcohol use disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020;5:239–50.

    PubMed  Google Scholar 

  200. Parvaz MA, Malaker P, Zilverstand A, Moeller SJ, Alia-Klein N, Goldstein RZ. Attention bias modification in drug addiction: enhancing control of subsequent habits. PNAS. 2021;118:23.

  201. DeVito EE, Worhunsky PD, Carroll KM, Rounsaville BJ, Kober H, Potenza MN. A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend. 2012;122:228–35.

    PubMed  Google Scholar 

  202. DeVito EE, Dong G, Kober H, Xu J, Carroll KM, Potenza MN. Functional neural changes following behavioral therapies and disulfiram for cocaine dependence. Psychol Addict Behav. 2017;31:534–47.

    PubMed  PubMed Central  Google Scholar 

  203. Carter CS, van Veen V. Anterior cingulate cortex and conflict detection: an update of theory and data. Cogn Affect Behav Neurosci. 2007;7:367–79.

    PubMed  Google Scholar 

  204. DeVito EE, Kober H, Carroll KM, Potenza MN. fMRI Stroop and behavioral treatment for cocaine-dependence: preliminary findings in methadone-maintained individuals. Addictive Behav. 2019;89:10–14.

    Google Scholar 

  205. Moeller SJ, Goldstein RZ. Impaired self-awareness in human addiction: deficient attribution of personal relevance. Trends Cogn Sci. 2014;18:635–41.

    PubMed  PubMed Central  Google Scholar 

  206. Wang A-L, Ruparel K, Loughead JW, Strasser AA, Blady SJ, Lynch KG, et al. Content matters: neuroimaging investigation of brain and behavioral impact of televised anti-tobacco public service announcements. J Neurosci. 2013;33:7420–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  207. Chua HF, Liberzon I, Welsh RC, Strecher VJ. Neural correlates of message tailoring and self-relatedness in smoking cessation programming. Biol Psychiatry. 2009;65:165–8.

    PubMed  Google Scholar 

  208. Chua HF, Ho SS, Jasinska AJ, Polk TA, Welsh RC, Liberzon I, et al. Self-related neural response to tailored smoking-cessation messages predicts quitting. Nat Neurosci. 2011;14:426–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  209. Wilson SJ, Sayette MA, Fiez JA. Neural correlates of self-focused and other-focused strategies for coping with cigarette cue exposure. Psychol Addictive Behav. 2013;27:466–76.

    Google Scholar 

  210. Garland EL, Howard MO. Mindfulness-based treatment of addiction: current state of the field and envisioning the next wave of research. Addiction Sci Clin Pract. 2018;13:14.

    Google Scholar 

  211. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006;13:27–45.

    PubMed  Google Scholar 

  212. Froeliger B, Mathew AR, McConnell PA, Eichberg C, Saladin ME, Carpenter MJ, et al. Restructuring reward mechanisms in nicotine addiction: a pilot fMRI study of mindfulness-oriented recovery enhancement for cigarette smokers. Evid Based Complement Altern Med. 2017;2017:7018014.

    CAS  Google Scholar 

  213. Westbrook C, Creswell JD, Tabibnia G, Julson E, Kober H, Tindle HA. Mindful attention reduces neural and self-reported cue-induced craving in smokers. Soc Cogn Affect Neurosci. 2013;8:73–84.

    PubMed  Google Scholar 

  214. Volkow ND, Li T-K. Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci. 2004;5:963–70.

    CAS  PubMed  Google Scholar 

  215. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;5:CD006103.

  216. Franklin T, Wang Z, Suh JJ, Hazan R, Cruz J, Li Y, et al. Effects of varenicline on smoking cue–triggered neural and craving responses. Arch Gen Psychiatry. 2011;68:516–26.

    CAS  PubMed  PubMed Central  Google Scholar 

  217. Culbertson CS, Bramen J, Cohen MS, London ED, Olmstead RE, Gan JJ, et al. Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. Arch Gen Psychiatry. 2011;68:505.

    PubMed  PubMed Central  Google Scholar 

  218. Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, et al. Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res. 2004;130:269–81.

    PubMed  PubMed Central  Google Scholar 

  219. Johansson BA, Berglund M, Lindgren A. Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review. Addiction. 2006;101:491–503.

    PubMed  Google Scholar 

  220. Srisurapanont M, Jarusuraisin N. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol. 2005;8:267–80.

    CAS  PubMed  Google Scholar 

  221. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O’Brien CP. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005;30:205–11.

    CAS  PubMed  Google Scholar 

  222. Beck A, Pelz P, Lorenz RC, Charlet K, Geisel O, Heinz A, et al. Effects of high-dose baclofen on cue reactivity in alcohol dependence: a randomized, placebo-controlled pharmaco-fMRI study. Eur Neuropsychopharmacol. 2018;28:1206–16.

    CAS  PubMed  Google Scholar 

  223. Myrick H, Li X, Randall PK, Henderson S, Voronin K, Anton RF. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol. 2010;30:365–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  224. Logge WB, Morris RW, Baillie AJ, Haber PS, Morley KC. Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals. Psychopharmacology. 2019. https://doi.org/10.1007/s00213-019-05192-5.

    Article  PubMed  Google Scholar 

  225. Holla B, Karthik S, Biswal J, Viswanath B, Jayarajan D, Bharath RD, et al. Brain functional magnetic resonance imaging cue-reactivity can predict baclofen response in alcohol use disorders. Clin Psychopharmacol Neurosci. 2018;16:290–301.

    PubMed  PubMed Central  Google Scholar 

  226. Volkow ND, Fowler JS, Wang G-J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004;47:3–13.

    CAS  PubMed  Google Scholar 

  227. Han DH, Kim SM, Choi JE, Min KJ, Renshaw PF. Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence. J Psychopharmacol. 2013;27:282–91.

    PubMed  PubMed Central  Google Scholar 

  228. Grodin EN, Ray LA. The use of functional magnetic resonance imaging to test pharmacotherapies for alcohol use disorder: a systematic review. Alcohol: Clin Exp Res. 2019;43:2038–56.

    Google Scholar 

  229. Liotti M, Mayberg HS. The role of functional neuroimaging in the neuropsychology of depression. J Clin Exp Neuropsychol. 2001;23:121–36.

    CAS  PubMed  Google Scholar 

  230. Goldstein RZ, Woicik PA, Maloney T, Tomasi D, Alia-Klein N, Shan J, et al. Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task. PNAS. 2010;107:16667–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  231. Moeller SJ, Tomasi D, Honorio J, Volkow ND, Goldstein RZ. Dopaminergic involvement during mental fatigue in health and cocaine addiction. Transl Psychiatry. 2012;2:e176.

    CAS  PubMed  PubMed Central  Google Scholar 

  232. Moeller SJ, Honorio J, Tomasi D, Parvaz MA, Woicik PA, Volkow ND, et al. Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction. Cereb Cortex. 2014;24:643–53.

    PubMed  Google Scholar 

  233. Moeller SJ, Konova AB, Tomasi D, Parvaz MA, Goldstein RZ. Abnormal response to methylphenidate across multiple fMRI procedures in cocaine use disorder: feasibility study. Psychopharmacology. 2016;233:2559–69.

    CAS  PubMed  PubMed Central  Google Scholar 

  234. Shi Z, Wang A-L, Jagannathan K, Fairchild VP, O’Brien CP, Childress AR, et al. Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder. J Psychiatry Neurosci. 2018;43:254–61.

    PubMed  PubMed Central  Google Scholar 

  235. Luigjes J, Segrave R, de Joode N, Figee M, Denys D. Efficacy of invasive and non-invasive brain modulation interventions for addiction. Neuropsychol Rev. 2019;29:116–38.

    PubMed  Google Scholar 

  236. Yuan K, Yu D, Bi Y, Wang R, Li M, Zhang Y, et al. The left dorsolateral prefrontal cortex and caudate pathway: new evidence for cue-induced craving of smokers. Hum Brain Mapp. 2017;38:4644–56.

    PubMed  PubMed Central  Google Scholar 

  237. Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M, et al. Depression of motor cortex excitability by low‐frequency transcranial magnetic stimulation. Neurology. 1997;48:1398–403.

    CAS  PubMed  Google Scholar 

  238. Siebner HR, Peller M, Willoch F, Minoshima S, Boecker H, Auer C, et al. Lasting cortical activation after repetitive TMS of the motor cortex: a glucose metabolic study. Neurology. 2000;54:956–63.

    CAS  PubMed  Google Scholar 

  239. Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction. 2009;104:653–60.

    PubMed  Google Scholar 

  240. Trojak B, Meille V, Achab S, Lalanne L, Poquet H, Ponavoy E, et al. Transcranial magnetic stimulation combined with nicotine replacement therapy for smoking cessation: a randomized controlled trial. Brain Stimul. 2015;8:1168–74.

    PubMed  Google Scholar 

  241. Su H, Zhong N, Gan H, Wang J, Han H, Chen T, et al. High frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex for methamphetamine use disorders: a randomised clinical trial. Drug Alcohol Depend. 2017;175:84–91.

    CAS  PubMed  Google Scholar 

  242. Bolloni C, Panella R, Pedetti M, Frascella AG, Gambelunghe C, Piccoli T, et al. Bilateral transcranial magnetic stimulation of the prefrontal cortex reduces cocaine intake: a pilot study. Front Psychiatry. 2016;7:133.

  243. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000;527:633–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  244. Boggio PS, Liguori P, Sultani N, Rezende L, Fecteau S, Fregni F. Cumulative priming effects of cortical stimulation on smoking cue-induced craving. Neurosci Lett. 2009;463:82–86.

    CAS  PubMed  Google Scholar 

  245. Fecteau S, Agosta S, Hone-Blanchet A, Fregni F, Boggio P, Ciraulo D, et al. Modulation of smoking and decision-making behaviors with transcranial direct current stimulation in tobacco smokers: a preliminary study. Drug Alcohol Depend. 2014;140:78–84.

    PubMed  PubMed Central  Google Scholar 

  246. da Silva MC, Conti CL, Klauss J, Alves LG, do Nascimento Cavalcante HM, Fregni F, et al. Behavioral effects of transcranial Direct Current Stimulation (tDCS) induced dorsolateral prefrontal cortex plasticity in alcohol dependence. J Physiol Paris. 2013;107:493–502.

    PubMed  Google Scholar 

  247. Klauss J, Penido Pinheiro LC, Silva Merlo BL, Correia Santos G, de A, Fregni F, et al. A randomized controlled trial of targeted prefrontal cortex modulation with tDCS in patients with alcohol dependence. Int J Neuropsychopharmacol. 2014;17:1793–803.

    PubMed  Google Scholar 

  248. Klauss J, Anders QS, Felippe LV, Nitsche MA, Nakamura-Palacios EM. Multiple sessions of transcranial direct current stimulation (tDCS) reduced craving and relapses for alcohol use: a randomized placebo-controlled trial in alcohol use disorder. Front Pharmacol. 2018;9:716.

  249. Batista EK, Klauss J, Fregni F, Nitsche MA, Nakamura-Palacios EM A Randomized Placebo-Controlled Trial of Targeted Prefrontal Cortex Modulation with Bilateral tDCS in Patients with Crack-Cocaine Dependence. Int J Neuropsychopharmacol. 2015;18:pyv066.

  250. de Almeida Ramos R, Taiar I, Trevizol AP, Shiozawa P, Cordeiro Q. Effect of a ten-day prefrontal transcranial direct current stimulation protocol for crack craving: a proof-of-concept trial. J ECT. 2016;32:e8.

    PubMed  Google Scholar 

  251. Conti CL, Nakamura-Palacios EM. Bilateral transcranial direct current stimulation over dorsolateral prefrontal cortex changes the drug-cued reactivity in the anterior cingulate cortex of crack-cocaine addicts. Brain Stimul. 2014;7:130–2.

    PubMed  Google Scholar 

  252. Gaudreault P-O, Sharma A, Datta A, Nakamura-Palacios EM, King S, Malaker P, et al. A double-blind sham-controlled phase 1 clinical trial of tDCS of the dorsolateral prefrontal cortex in cocaine inpatients: craving, sleepiness, and contemplation to change. Eur J Neurosci. 2021. https://doi.org/10.1111/ejn.15172.

    Article  PubMed  Google Scholar 

  253. Kim D-Y, Yoo S-S, Tegethoff M, Meinlschmidt G, Lee J-H. The inclusion of functional connectivity information into fMRI-based neurofeedback improves its efficacy in the reduction of cigarette cravings. J Cogn Neurosci. 2015;27:1552–72.

    PubMed  Google Scholar 

  254. Canterberry M, Hanlon CA, Hartwell KJ, Li X, Owens M, LeMatty T, et al. Sustained reduction of nicotine craving with real-time neurofeedback: exploring the role of severity of dependence. Nicotine Tob Res. 2013;15:2120–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  255. Hanlon CA, Hartwell KJ, Canterberry M, Li X, Owens M, LeMatty T, et al. Reduction of cue-induced craving through realtime neurofeedback in nicotine users: the role of region of interest selection and multiple visits. Psychiatry Res. 2013;213:79–81.

    PubMed  PubMed Central  Google Scholar 

  256. Karch S, Keeser D, Hümmer S, Paolini M, Kirsch V, Karali T, et al. Modulation of craving related brain responses using real-time fMRI in patients with alcohol use disorder. PLOS One. 2015;10:e0133034.

    PubMed  PubMed Central  Google Scholar 

  257. Martz ME, Hart T, Heitzeg MM, Peltier SJ. Neuromodulation of brain activation associated with addiction: a review of real-time fMRI neurofeedback studies. NeuroImage Clin. 2020;27:102350.

    PubMed  PubMed Central  Google Scholar 

  258. Corominas-Roso M, Ibern I, Capdevila M, Ramon R, Roncero C, Ramos-Quiroga JA. Benefits of EEG-neurofeedback on the modulation of impulsivity in a sample of cocaine and heroin long-term abstinent inmates: a pilot study. Int J Offender Ther Comp Criminol. 2020;64:1275–98.

    CAS  PubMed  Google Scholar 

  259. Stewart JL, May AC, Paulus MP. Bouncing back: brain rehabilitation amid opioid and stimulant epidemics. NeuroImage Clin. 2019;24:102068.

    PubMed  PubMed Central  Google Scholar 

  260. Sokhadze TM, Cannon RL, Trudeau DL. EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. Appl Psychophysiol Biofeedback. 2008;33:1–28.

    PubMed  PubMed Central  Google Scholar 

  261. Kirschner M, Sladky R, Haugg A, Stämpfli P, Jehli E, Hodel M, et al. Self-regulation of the dopaminergic reward circuit in cocaine users with mental imagery and neurofeedback. EBioMedicine. 2018;37:489–98.

    PubMed  PubMed Central  Google Scholar 

  262. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–60.

    CAS  PubMed  Google Scholar 

  263. Schlaepfer TE, Bewernick BH. Deep brain stimulation for major depression. Handb Clin Neurol. 2013;116:235–43.

    CAS  PubMed  Google Scholar 

  264. Benabid AL. Deep brain stimulation for Parkinson’s disease. Curr Opin Neurobiol. 2003;13:696–706.

    CAS  PubMed  Google Scholar 

  265. Wang TR, Moosa S, Dallapiazza RF, Elias WJ, Lynch WJ. Deep brain stimulation for the treatment of drug addiction. Neurosurg Focus. 2018;45:E11.

    PubMed  PubMed Central  Google Scholar 

  266. Heinze H-J, Heldmann M, Voges J, Hinrichs H, Marco-Pallares J, Hopf J-M, et al. Counteracting incentive sensitization in severe alcohol dependence using deep brain stimulation of the nucleus accumbens: clinical and basic science aspects. Front Hum Neurosci. 2009;3:22.

  267. Kuhn J, Gründler TOJ, Bauer R, Huff W, Fischer AG, Lenartz D, et al. Successful deep brain stimulation of the nucleus accumbens in severe alcohol dependence is associated with changed performance monitoring. Addict Biol. 2011;16:620–3.

    PubMed  Google Scholar 

  268. Müller UJ, Sturm V, Voges J, Heinze H-J, Galazky I, Heldmann M, et al. Successful treatment of chronic resistant alcoholism by deep brain stimulation of nucleus accumbens: first experience with three cases. Pharmacopsychiatry. 2009;42:288–91.

    PubMed  Google Scholar 

  269. Gonçalves-Ferreira A, Couto FS, do, Campos AR, Neto LPL, Gonçalves-Ferreira D, Teixeira J. Deep brain stimulation for refractory cocaine dependence. Biol Psychiatry. 2016;79:e87–e89.

    PubMed  Google Scholar 

  270. Kuhn J, Möller M, Treppmann JF, Bartsch C, Lenartz D, Gruendler TOJ, et al. Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction. Mol Psychiatry. 2014;19:145–6.

    CAS  PubMed  Google Scholar 

  271. Valencia-Alfonso C-E, Luigjes J, Smolders R, Cohen MX, Levar N, Mazaheri A, et al. Effective deep brain stimulation in heroin addiction: a case report with complementary intracranial electroencephalogram. Biol Psychiatry. 2012;71:e35–e37.

    PubMed  Google Scholar 

  272. Wakeford AGP, Morin EL, Bramlett SN, Howell LL, Sanchez MM. A review of nonhuman primate models of early life stress and adolescent drug abuse. Neurobiol Stress. 2018;9:188–98.

    PubMed  PubMed Central  Google Scholar 

  273. Ersche KD, Meng C, Ziauddeen H, Stochl J, Williams GB, Bullmore ET, et al. Brain networks underlying vulnerability and resilience to drug addiction. Proc Natl Acad Sci USA. 2020;117:15253–61.

    PubMed  PubMed Central  Google Scholar 

  274. Nastase SA, Goldstein A, Hasson U. Keep it real: rethinking the primacy of experimental control in cognitive neuroscience. NeuroImage 2020;222:117254.

    PubMed  Google Scholar 

  275. Agurto C, Norel R, Pietrowicz M, Parvaz M, Kinreich S, Bachi K, et al. Speech markers for clinical assessment of cocaine users. 2019 IEEE International Conference on Acoustics Speech and Signal Processing. 2019;2019:6391–4.

  276. Gueguen MC, Schweitzer EM, Konova AB. Computational theory-driven studies of reinforcement learning and decision-making in addiction: what have we learned? Curr Opin Behav Sci. 2021;38:40–48.

    PubMed  Google Scholar 

  277. Crummy EA, O’Neal TJ, Baskin BM, Ferguson SM. One is not enough: understanding and modeling polysubstance use. Front Neurosci. 2020;14:569.

  278. Ekhtiari H, Tavakoli H, Addolorato G, Baeken C, Bonci A, Campanella S, et al. Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead. Neurosci Biobehav Rev. 2019;104:118–40.

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

RZG is supported by grants from the National Institute on Drug Abuse (R01DA048301, R01DA041528, R01DA047851, 271201800035C) and the National Center for Complementary and Integrative Health (R01AT010627). CWB is supported by the National Institute on Drug Abuse Intramural Research Program.

Author information

Affiliations

Authors

Contributions

AOC, CWB, and RZG wrote the manuscript.

Corresponding author

Correspondence to Rita Z. Goldstein.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ceceli, A.O., Bradberry, C.W. & Goldstein, R.Z. The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex. Neuropsychopharmacol. 47, 276–291 (2022). https://doi.org/10.1038/s41386-021-01153-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41386-021-01153-9

Further reading

Search

Quick links